Synthesis of anionic poly(ethylene glycol) derivative for chitosan surface modificarion in blood-contacting applications

Carbohydrate Polymers

Volumn 32, Issue 3-4, 1997, Pages 193-199

  Amiji, Mansoor M ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BIOSYNTHESIS; BLOOD; CHEMICAL MODIFICATION; COAGULATION; COMPLEXATION; DERIVATIVES; ELECTRON MICROSCOPY; POLYELECTROLYTES; POLYETHYLENE GLYCOLS; SURFACE TREATMENT;

CHITOSAN; COMPLEXATION INTERPRETATION METHOD; ELECTRON MICROSCOPY FOR CHEMICAL ANALYSIS (ESCA); ETHYLENE OXIDES;

CHITIN;

EID: 0031100673     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0144-8617(97)00006-4     Document Type: Article

References (26)

1. Akizawa, T., Kino, K., Koshikawa, S., Ikada, Y., Kishida, A., Yamashita, M. and Imamura, K. (1989) Efficiency and biocompatibility of a polyethylene glycol grafted cellulosic membrane during hemodialysis. Transactions of the American Society of Artificial Internal Organs 35, 333-335.
2. Amiji, M. (1995) Permeability and blood compatibility properties of chitosan-poly(ethylene oxide) blend membranes for hemodialysis. Biomaterials 16, 593-599.
3. Amiji, M. (In press) Surface modification of chitosan membranes by complexation-interpenetration of anionic polysaccharides for improved blood compatibility in hemodialysis. Journal of Biomaterial Science, Polymer Edition.
4. Amiji, M. and Park, K. (1992) Prevention of protein adsorption and platelet adhesion on surfaces by PEO/ PPO/PEO triblock copolymers. Biomaterials 13, 682-692.
5. Amiji, M. and Park, K. (1994) Surface modification of polymeric biomaterials with poly(ethylene oxide): A steric repulsion approach, in Polymers of Biological and Biomedical Significance, ed. S. W. Shalaby, Y. Ikada, R. Langer and J. Williams. ACS Symposium Series Publication, Vol. 540. American Chemical Society, Washington, DC (1994) pp. 135-146.
6. Amiji, M. and Park, K. (1995) Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity, in Polymer Biomaterials: In Solution, as Interfaces, and as Solids, eds S. L. Cooper, C. H. Bamford and T. Tsuruta. VSP, The Netherlands, pp. 535-552.
7. Anderson, J. M. and Kottke-Merchant, K. (1985) Platelet interaction with biomaterials and artificial devices. CRC Critical Reviews of Biocompatibility 1, 111-204.
8. Baier, R. E. (1978) Key events in blood interactions. Artifiual Organs 2, 422-426.
9. Baier, R. E., DePalma, V. A., Goupil, D. W. and Cohen, E. (1985) Human platelet spreading on substrata of known surface chemistry. Journal of Biomedical Materials Research 19, 1157-1167.
10. Brown, B. A. (1993) Hematology: Principles and Procedures, 6th Edn. Lea and Febiger, Philadelphia, PA, p. 220.
11. Chandy, T. and Sharma, C. P. (1990) Chitosan as a biomaterial. Biomaterials, Artificial Cells and Artificial Organs 18, 1-24.
12. Desai, N. P. and Hubbell, J. A. (1991) Solution technique to incorporate polyethylene oxide and other water soluble polymers into the surfaces of polymeric biomaterials. Biomaterials 12, 144-153.
13. Hirano, S., Noishiki, Y., Kinugawa, J., Higashima, H. and Hayashi, T. (1987) Chitin and chitosan for use as a novel biomedical material, in Advances in Biomedical Polymers, ed. G. C. Gebelien. Plenum Press, New York, pp. 285-297.
14. Hoffman, A. S. (1982) Blood-biomaterial interactions: An overview, in Biomaterials: Interfacial Phenomena and Applications, Vol. 199, ed. S.L. Copper and N. A. Peppas. American Chemical Society, Washington, DC, pp. 3-8.
15. Hoffman, A. S. (1987) Modification of material surfaces to affect how they interact with blood. Annals of the New York Academy of Sciences 516, 96-101.
16. Ikada, Y. (1984) Blood-compatible surfaces. Advances in Polymer Science 57, 103-140.
17. Li, Q., Dunn, E. T., Grandmaison, E. W. and Goosen, M. F.A. (1992) Applications and properties of chitosan. Journal of Bioactive and Compatible Polymers 7, 370-397.
18. Murata, J.-I., Ohya, Y. and Ouchi, T. (1996) Possibility of application of quaternary chitosan having pendant galactose residues as gene delivery tool. Carbohydrate Polymers 29, 69-74.
19. Naito, K. and Fujikawa, K. (1991) Activation of the human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. Journal of Biological Chemistry 266, 7353-7358.
20. Park, K., Mao, F. W. and Park, H. (1990) Morphological characterization of surface induced platelet activation. Biomaterials 11, 24-31.
21. Park, K., Mao, F. W. and Park, H. (1991) The minimum surface fibrinogen concentration necessary for platelet activation on dimethyldichlorosilane-coated glass. Journal of Biomedical Materials Research 25, 407-420.
22. Patel, V. R. and Amiji, M. (1996) pH-sensitive swelling and drug release properties of chitosan-poly(ethylene oxide) semi-interpenetrating polymer network, in Hydrogels and Biodegradable Polymers for Bioapplications, ed. R. Ottenbrite, S. Huang and K. Park. ACS Symposium Series Publication. Volume 627. American Chemical Society, Washington, DC, pp. 209-220.
23. Renaud, S. (1969) The recalcification plasma clotting time. A valuable general clotting test in man and rats. Canadian Journal of Physiology and Pharmacology 47, 689-693.
24. Rhodes, N. P. and Williams, D. F. (1994) Plasma recalcification time as a measure of the contact phase activation and heparinization efficiency after contact with biomaterials. Biomaterials 15, 35-37.
25. Scofield, J. Hartree-Slater (1976) subshell photoionization cross-sections at 1254 and 1487eV. Journal of Electron Spectroscopy and Related Phenomenom 8, 129-134.
26. Silverberg, M. and Diehl, S. V. (1987) The activation of the contact system of human plasma by polysaccharide sulfates. Annals of the New York Academy of Sciences 516, 268-279.